“…In particular, several studies have reported that low concentrations of myomiRs in blood correlate with poor prognosis in non-small cell lung cancer, melanoma, astrocytoma, or osteosarcoma patients (Hu et al, 2010;Li et al, 2014; Soares et al, 2014Soares et al, miR-147, miR-205-3p, miR-229a3p, miR-233 3p, miR-431-5p, miR-511-3p, miR-665-3p, miR-1933 Mice muscles Lee et al, 2017Lee et al, miR-10b-5p, 1249Lee et al, -3p, miR-144-3p, miR-144-5p, miR-146a-5p, miR-146b-5p, miR-181c-3p, miR-183-5p, miR-1843a Mice muscles Fernandez et al, 2019Fernandez et al, miR-3184-3p, miR-423-5p, let-7d-3p, miR-1296 Human skeletal muscle Zhang C. et al, 2014;Tian et al, 2015). This because skeletal muscle, under physiological conditions, continuously releases exosomes contained myomiRs in the blood (Guescini et al, 2015), but in advanced cancers, when a substantial reduction of muscle mass occurs, there is a consequent decrease in circulating myomiRs.…”